The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I (safety assessment) of durvalumab (MEDI4736) with focal sensitizing radiotherapy in platinum resistant ovarian, primary peritoneal or fallopian tube epithelial carcinoma.
 
Anna Tinker
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca/MedImmune (Inst)
Other Relationship - AstraZeneca
 
Peter Lim
No Relationships to Disclose
 
Christina Aquino-Parsons
No Relationships to Disclose
 
Paul Hoskins
Consulting or Advisory Role - Ortho-McNeil Janssen Scientific Affairs LLC
Travel, Accommodations, Expenses - AstraZeneca
 
Daniel Khalaf
Consulting or Advisory Role - Bayer
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Kathy Han
No Relationships to Disclose
 
Mitchell Liu
No Relationships to Disclose
 
Julian J Lum
Honoraria - Agios
Research Funding - Immunome
Patents, Royalties, Other Intellectual Property - Patents only
Travel, Accommodations, Expenses - Agios; Genentech